Logo Image
|Articles|May 1, 2019

Global Harmonized Testing Services

Eurofins BioPharma Product Testing is the largest network of bio/pharmaceutical GMP product testing laboratories providing comprehensive laboratory services for the world’s largest bio/pharmaceutical companies.

Eurofins BioPharma Product Testing is the largest network of bio/pharmaceutical GMP product testing laboratories providing comprehensive laboratory services for the world’s largest bio/pharmaceutical companies. With a global capacity of more than 1,200,000 square feet, our network of 28 laboratories operates under the same strict quality procedures and LIMS worldwide.

 

Products and Services

Eurofins BioPharma Product Testing provides testing services for all stages of the drug development process and supports all functional areas of bio/pharmaceutical manufacturing, including method development, microbiology, process validation and quality control. We offer clients the flexibility to choose from three service models, including our award-winning PSS Insourcing Solutions.

 

Eurofins BioPharma Product Testing 
2425 New Holland Pike, Lancaster, PA 17601
pharma@eurofins.com
tel. 717.656.2300
BIO International Booth #2949

Related to this article

View more
The BioPharm Brief: A $7 Billion Oncology Option Deal, a TL1A Pivot, and Oral Adalimumab Heads to the Clinic
The BioPharm Brief: A $7 Billion Oncology Option Deal, a TL1A Pivot, and Oral Adalimumab Heads to the Clinic
Boehringer Ingelheim licenses six preclinical ADC and T-cell engager programs from Sino Biopharmaceutical in a deal worth up to $7 billion, Spyre Therapeutics drops anti-TL1A antibody SPY072 in rheumatic diseases after phase 2 misses and turns to hidradenitis suppurativa, and Biora Therapeutics gets ethics approval for a first-in-human trial of its BioJet oral adalimumab capsule.
Read more
The Promise of Microgravity for R&D and Manufacturing
The Promise of Microgravity for R&D and Manufacturing
As access to low Earth orbit expands, space-based research is opening possibilities in drug discovery, formulation, and manufacturing. In Part 1, the authors look at how microgravity changes biology and chemistry in ways that can’t be reproduced on Earth and where it fits from target discovery to life cycle management.
Read more